INS and obesity due to melanocortin 4 receptor deficiency: In our study, metabolic control improved throughout the period analyzed (Fig. 2), and the use of intensive therapy and insulin analogs in the 2007 and 2018 groups was not associated with a higher risk of overweight and obesity.